Show simple item record

dc.contributor.authorNeuzil, Kathleen M
dc.date.accessioned2021-06-07T16:51:58Z
dc.date.available2021-06-07T16:51:58Z
dc.date.issued2021-05-05
dc.identifier.urihttp://hdl.handle.net/10713/15937
dc.description.urihttps://doi.org/10.1056/NEJMe2103931en_US
dc.language.isoenen_US
dc.publisherMassachusetts Medical Societyen_US
dc.relation.ispartofNew England Journal of Medicineen_US
dc.subjectvariantsen_US
dc.subject.meshCOVID-19 Vaccinesen_US
dc.subject.meshMutationen_US
dc.subject.meshPandemics--prevention & controlen_US
dc.subject.meshSARS-CoV-2--geneticsen_US
dc.titleInterplay between Emerging SARS-CoV-2 Variants and Pandemic Controlen_US
dc.typeArticleen_US
dc.identifier.doi10.1056/NEJMe2103931
dc.identifier.pmid33951359
dc.source.volume384
dc.source.issue20
dc.source.beginpage1952
dc.source.endpage1954
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record